{"transactions":[{"id":705597,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-20T21:36:58.000Z","date":"2026-07-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service."}],"balance_after":318750,"source":{"system":"sec-edgar","filing":"0001477932-26-004404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793226004404/form4.xml","form_type":"4"}},{"id":904651,"issuer":{"id":6495,"kind":"organization","name":"Z Squared Inc.","symbol":"ZSQR"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-13T22:00:05.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind."}],"balance_after":13161,"source":{"system":"sec-edgar","filing":"0001683168-26-001025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000168316826001025/ownership.xml","form_type":"4"}},{"id":904650,"issuer":{"id":6495,"kind":"organization","name":"Z Squared Inc.","symbol":"ZSQR"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-02-13T22:00:05.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":5700,"price":10.56,"value":60192.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the exercise price of shares purchased upon exercise of stock options."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind."}],"balance_after":13161,"source":{"system":"sec-edgar","filing":"0001683168-26-001025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000168316826001025/ownership.xml","form_type":"4"}},{"id":955651,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Options","published_at":"2026-01-02T22:24:01.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share, (v) options to purchase 250,000 shares exercisable at $2.45 per share, and (vi) options to purchase 250,000 exercisable at $1.10 per share."}],"balance_after":761544,"derivative":{"exercise_price":1.1,"exercise_date":"2025-12-31","expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001683168-26-000041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316826000041/ownership.xml","form_type":"4"}},{"id":991025,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-21T11:32:50.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":2.55,"value":127500.0,"ownership":{"direct":false,"nature":"Trustee"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"50,000 shares were purchased at $2.55 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee.\nThese shares are considered indirect ownership of Gene Salkind."}],"balance_after":218750,"source":{"system":"sec-edgar","filing":"0001477932-25-008535","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225008535/form4.xml","form_type":"4"}},{"id":995197,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-19T02:40:18.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":2.81,"value":281000.0,"ownership":{"direct":false,"nature":"Trustee"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"100,000 shares were purchased at $2.81 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee. These shares are considered indirect ownership of Gene Salkind."}],"balance_after":168750,"source":{"system":"sec-edgar","filing":"0001477932-25-008466","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225008466/form4.xml","form_type":"4"}},{"id":995196,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-19T02:40:18.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":2.65,"value":265000.0,"ownership":{"direct":true},"balance_after":569470,"source":{"system":"sec-edgar","filing":"0001477932-25-008466","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225008466/form4.xml","form_type":"4"}},{"id":1035802,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible notes","published_at":"2025-09-19T21:00:05.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share."}],"balance_after":511544,"derivative":{"exercise_price":1,"exercise_date":"2025-09-15","expiration_date":"2025-10-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001683168-25-007156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316825007156/ownership.xml","form_type":"4"}},{"id":1035801,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T21:00:05.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents interest paid on a convertible note"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust."}],"balance_after":8668695,"source":{"system":"sec-edgar","filing":"0001683168-25-007156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316825007156/ownership.xml","form_type":"4"}},{"id":1078946,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-30T20:47:19.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Vests quarterly in equal installments over 12 months beginning July 1, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":585370,"source":{"system":"sec-edgar","filing":"0001477932-25-005338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225005338/form4.xml","form_type":"4"}},{"id":1078945,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-30T20:47:19.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Vests in full 90 days from July 1, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":435370,"source":{"system":"sec-edgar","filing":"0001477932-25-005338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225005338/form4.xml","form_type":"4"}},{"id":1078944,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-30T20:47:19.000Z","date":"2025-07-11","kind":"purchase","planned":false,"acquired":true,"shares":20243,"price":4.94,"value":100000.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased these shares pursuant to a private placement offering conducted by the Issuer. The Common Stock is being offered pursuant to the exemption from registration under\nSection 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws."}],"balance_after":385370,"source":{"system":"sec-edgar","filing":"0001477932-25-005338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225005338/form4.xml","form_type":"4"}},{"id":1165448,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Options to buy common stock","published_at":"2025-04-25T20:01:17.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the options vest on April 17, 2026."}],"balance_after":35000,"derivative":{"exercise_price":2.28,"expiration_date":"2035-04-17","underlying":"Common","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001477932-25-002979","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225002979/form4.xml","form_type":"4"}},{"id":1165447,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Options to buy common stock","published_at":"2025-04-25T20:01:17.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.46,"exercise_date":"2025-04-17","expiration_date":"2035-01-17","underlying":"Common","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001477932-25-002979","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225002979/form4.xml","form_type":"4"}},{"id":1165446,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-04-25T20:01:17.000Z","date":"2025-04-17","kind":"purchase","planned":false,"acquired":true,"shares":241229,"price":2.28,"value":550002.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. The shares are restricted securities subject to transfer restrictions under Rule 144 of the Securities Act until such time that they are registered pursuant to a registration statement or become eligible for resale otherwise."}],"balance_after":365127,"source":{"system":"sec-edgar","filing":"0001477932-25-002979","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793225002979/form4.xml","form_type":"4"}},{"id":1219062,"issuer":{"id":6495,"kind":"organization","name":"Z Squared Inc.","symbol":"ZSQR"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Options (right to buy)","published_at":"2025-03-06T22:28:10.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":5700,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date is ten years from the day of grant."}],"balance_after":8950,"derivative":{"exercise_price":10.56,"underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001683168-25-001392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000168316825001392/ownership.xml","form_type":"4"}},{"id":1319031,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible notes","published_at":"2025-01-02T21:05:05.000Z","date":"2024-12-30","kind":"other","planned":false,"acquired":false,"shares":210000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share."}],"balance_after":411544,"derivative":{"exercise_price":0.5,"exercise_date":"2024-07-25","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001683168-25-000023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316825000023/ownership.xml","form_type":"4"}},{"id":1319030,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-01-02T21:05:05.000Z","date":"2024-12-30","kind":"other","planned":false,"acquired":true,"shares":420000,"price":0.5,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust."}],"balance_after":8643695,"source":{"system":"sec-edgar","filing":"0001683168-25-000023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316825000023/ownership.xml","form_type":"4"}},{"id":1383634,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Options","published_at":"2024-10-21T23:53:52.000Z","date":"2024-10-08","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The securities listed in Table II are securities owned directly by Dr. Salkind and his wife and by a family trust."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 420,000 common shares underlying convertible notes, (ii) 59,211 shares underlying warrants exercisable at $60 per share, (iii) 2,333 shares underlying options exercisable at $68.48 per share, (iv) 100,000 shares underlying options exercisable at $.20 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share."}],"balance_after":831544,"derivative":{"exercise_price":2.45,"exercise_date":"2024-10-08","expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001683168-24-007267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316824007267/ownership.xml","form_type":"4"}},{"id":1425857,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series H Preferred Stock","published_at":"2024-08-22T20:00:04.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":false,"shares":751973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (i) 420,000 common shares underlying convertible notes, (ii) 59,211 shares underlying warrants exercisable at $60 per share, (iii) 2,333 shares underlying options exercisable at $68.48 per share and (iv) 100,000 shares underlying options exercisable at $.20 per share."}],"balance_after":581544,"derivative":{"exercise_price":0.2,"exercise_date":"2023-12-15","underlying":"Common Stock","underlying_shares":7519730},"source":{"system":"sec-edgar","filing":"0001683168-24-005963","document":"salkind_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316824005963/salkind_f4.xml","form_type":"4/A","original_submission_date":"2024-08-08"}},{"id":1425856,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-22T20:00:04.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":true,"shares":7675160,"price":0.2,"value":1535032.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Includes dividend shares issued upon conversion."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust."}],"balance_after":8223695,"source":{"system":"sec-edgar","filing":"0001683168-24-005963","document":"salkind_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316824005963/salkind_f4.xml","form_type":"4/A","original_submission_date":"2024-08-08"}},{"id":1438099,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series H Preferred Stock","published_at":"2024-08-09T00:19:51.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":false,"shares":751973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":616201,"derivative":{"exercise_price":0.2,"exercise_date":"2023-12-15","underlying":"Common Stock","underlying_shares":7519730},"source":{"system":"sec-edgar","filing":"0001683168-24-005385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316824005385/ownership.xml","form_type":"4"}},{"id":1438098,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-09T00:19:51.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":true,"shares":7675160,"price":0.2,"value":1535032.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Includes dividend shares issued upon conversion."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust."}],"balance_after":8223695,"source":{"system":"sec-edgar","filing":"0001683168-24-005385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316824005385/ownership.xml","form_type":"4"}},{"id":1447487,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Notes","published_at":"2024-07-30T01:38:47.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":8135931,"derivative":{"exercise_price":0.5,"exercise_date":"2024-07-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001683168-24-005116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316824005116/ownership.xml","form_type":"4"}},{"id":1466429,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Notes","published_at":"2024-07-02T01:30:03.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":160000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":8035931,"derivative":{"exercise_price":0.5,"exercise_date":"2024-06-27","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001683168-24-004578","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316824004578/ownership.xml","form_type":"4"}},{"id":1682298,"issuer":{"id":6495,"kind":"organization","name":"Z Squared Inc.","symbol":"ZSQR"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T22:31:41.000Z","date":"2024-01-05","kind":"purchase","planned":false,"acquired":true,"shares":11600,"price":0.69,"value":8004.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 95,817 shares of common stock that are held as JTWROS with Catherine Salkind, (ii) 57,268 shares of common stock issuable\nupon exercise of currently exercisable warrants held as JTWROS with Catherine Salkind, (iii) 101,061 shares of common stock that are\nissuable upon currently exercisable warrants and (iv) 30,000 shares of common stock that are issuable upon exercise of options that are or will\nbecome exercisable in the next 60 days."}],"balance_after":284056,"source":{"system":"sec-edgar","filing":"0001683168-24-000161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000168316824000161/ownership.xml","form_type":"4"}},{"id":1705665,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock options","published_at":"2023-12-19T22:00:14.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust. Salkind and the trust exchanged Series G preferred stock for series H preferred Stock with an issue value of $1,503,495."}],"balance_after":7715931,"derivative":{"exercise_price":0.2,"exercise_date":"2023-12-19","expiration_date":"2028-12-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001683168-23-008965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823008965/ownership.xml","form_type":"4"}},{"id":1705664,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock Series H","published_at":"2023-12-19T22:00:14.000Z","date":"2023-12-15","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":751973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust. Salkind and the trust exchanged Series G preferred stock for series H preferred Stock with an issue value of $1,503,495."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust. Salkind and the trust exchanged Series G preferred stock for series H preferred Stock with an issue value of $1,503,495."}],"balance_after":7615931,"derivative":{"exercise_price":0.2,"exercise_date":"2023-12-15","underlying":"Common Stock","underlying_shares":7519730},"source":{"system":"sec-edgar","filing":"0001683168-23-008965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823008965/ownership.xml","form_type":"4"}},{"id":1705663,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock Series G","published_at":"2023-12-19T22:00:14.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":false,"shares":300789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust. Salkind and the trust exchanged Series G preferred stock for series H preferred Stock with an issue value of $1,503,495."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust. Salkind and the trust exchanged Series G preferred stock for series H preferred Stock with an issue value of $1,503,495."}],"balance_after":3103990,"derivative":{"exercise_price":0.5,"exercise_date":"2023-11-07","underlying":"Common Stock","underlying_shares":3007789},"source":{"system":"sec-edgar","filing":"0001683168-23-008965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823008965/ownership.xml","form_type":"4"}},{"id":1746042,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock","published_at":"2023-11-09T19:41:07.000Z","date":"2023-11-07","kind":"grant","planned":false,"acquired":true,"shares":300789,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Salkind and his trust invested an additional $1,200,000 plus converted the $300,000 principal loan plus interest of $3,495 (totaling$1,503,495) into shares of Series G Preferred Stock, convertible at holders option at any time into common stock at an effective price of $.50 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Salkind and his trust invested an additional $1,200,000 plus converted the $300,000 principal loan plus interest of $3,495 (totaling$1,503,495) into shares of Series G Preferred Stock, convertible at holders option at any time into common stock at an effective price of $.50 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":3103990,"derivative":{"exercise_price":5,"exercise_date":"2023-11-07","underlying":"Common Stock","underlying_shares":3007890},"source":{"system":"sec-edgar","filing":"0001683168-23-007787","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823007787/ownership.xml","form_type":"4"}},{"id":1746041,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T19:41:07.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"reported_value":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Salkind and his trust invested an additional $1,200,000 plus converted the $300,000 principal loan plus interest of $3,495 (totaling$1,503,495) into shares of Series G Preferred Stock, convertible at holders option at any time into common stock at an effective price of $.50 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. Salkind has the right to convert $300,000 loan into common stock at $.70 per share or into the terms of a financing completed before November 30, 2023."}],"balance_after":96100,"derivative":{"exercise_price":0.7,"exercise_date":"2023-10-06","expiration_date":"2023-11-30","underlying":"Common Stock","underlying_shares":428571},"source":{"system":"sec-edgar","filing":"0001683168-23-007787","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823007787/ownership.xml","form_type":"4"}},{"id":1746040,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T19:40:01.000Z","date":"2023-10-06","kind":"grant","planned":false,"acquired":true,"reported_value":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. Salkind has the right to convert $300,000 loan into common stock at $.70 per share or into the terms of a financing completed before November 30, 2023."}],"balance_after":524671,"derivative":{"exercise_price":0.7,"exercise_date":"2023-10-06","expiration_date":"2023-11-30","underlying":"Common Stock","underlying_shares":428571},"source":{"system":"sec-edgar","filing":"0001683168-23-007786","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823007786/ownership.xml","form_type":"4/A","original_submission_date":"2023-10-10"}},{"id":1746039,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T19:40:01.000Z","date":"2023-10-06","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0.65,"value":97500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 448,535 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee."}],"balance_after":448535,"source":{"system":"sec-edgar","filing":"0001683168-23-007786","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823007786/ownership.xml","form_type":"4/A","original_submission_date":"2023-10-10"}},{"id":1762893,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-11T00:18:34.000Z","date":"2023-10-06","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0.65,"value":97500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 448,535 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee."}],"balance_after":448535,"source":{"system":"sec-edgar","filing":"0001683168-23-007040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823007040/ownership.xml","form_type":"4"}},{"id":1792757,"issuer":{"id":6495,"kind":"organization","name":"Z Squared Inc.","symbol":"ZSQR"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T19:15:59.000Z","date":"2023-08-29","kind":"purchase","planned":false,"acquired":true,"shares":4006,"price":1.01,"value":4046.06,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Julian R Salkind Trust DTD 10/11/94, for which the Reporting Person is the Trustee."}],"balance_after":4046,"source":{"system":"sec-edgar","filing":"0001683168-23-006169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000168316823006169/ownership.xml","form_type":"4"}},{"id":1792756,"issuer":{"id":6495,"kind":"organization","name":"Z Squared Inc.","symbol":"ZSQR"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-30T19:15:59.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":28638,"price":0.91,"value":26060.58,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Marital Trust GST Subject U/W/O Leopold Salkind, for which the Reporting Person is the trustee."}],"balance_after":28638,"source":{"system":"sec-edgar","filing":"0001683168-23-006169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000168316823006169/ownership.xml","form_type":"4"}},{"id":1920508,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T00:42:44.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":1385663,"price":0.17,"value":235562.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 4,478,017 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee."}],"balance_after":4478017,"source":{"system":"sec-edgar","filing":"0001683168-23-002368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823002368/ownership.xml","form_type":"4"}},{"id":1924046,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-06T20:43:00.000Z","date":"2023-04-06","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0.167,"value":21710.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 3,092,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee."}],"balance_after":3092354,"source":{"system":"sec-edgar","filing":"0001683168-23-002202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316823002202/ownership.xml","form_type":"4"}},{"id":2039911,"issuer":{"id":6495,"kind":"organization","name":"Z Squared Inc.","symbol":"ZSQR"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Options (right to buy)","published_at":"2023-01-31T16:03:15.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next\n 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date is ten years from the day of grant."}],"balance_after":30000,"derivative":{"exercise_price":1.6,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-23-000434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000168316823000434/ownership.xml","form_type":"4"}},{"id":2111539,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option Grant (right to buy)","published_at":"2022-11-17T21:16:02.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option provides for vesting in equal monthly installments for the two-year period starting on July 1, 2022 and ending on July 1, 2024; therefore, on the grant date of September 30, 2022, such options immediately vested for 3 months and thereafter will continue to vest on a monthly basis for the succeeding 21 months."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option provides for vesting in equal monthly installments for the two-year period starting on July 1, 2022 and ending on July 1, 2024; therefore, on the grant date of September 30, 2022, such options immediately vested for 3 months and thereafter will continue to vest on a monthly basis for the succeeding 21 months."}],"balance_after":50000,"derivative":{"exercise_price":3.87,"expiration_date":"2027-09-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-22-011497","document":"form4-11172022_091143.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000141588922011497/form4-11172022_091143.xml","form_type":"4"}},{"id":2215457,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2022-07-06T01:34:42.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":204000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 2,992,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust."},{"field":"security","element":"securityTitle","label":"F2","text":"The board of directors of the issuer accepted Dr. Salkind's offer to convert $510,000 of convertible notes at a reduced conversion price of $1.25 per share into 408,000 common shares and warrants to purchase 204,000 shares at an exercise price of $4.00 per share through September 30, 2029."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"1,441,500 derivative securities include the following: (i) 390,625 common stock purchase warrants exercisable at $4.00 per share through September 2023; (ii) 10-year options to purchase 35,000 shares granted on December 8, 2021; and (iii) warrants to purchase 1,015,875 shares exercisable through September 30, 2029 which were issuable on June 30, 2022 as a result of the note conversion."}],"balance_after":1441500,"derivative":{"exercise_price":4,"exercise_date":"2022-06-30","expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001683168-22-004784","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316822004784/ownership.xml","form_type":"4"}},{"id":2215456,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Notes","published_at":"2022-07-06T01:34:42.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":510000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 2,992,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust."},{"field":"security","element":"securityTitle","label":"F2","text":"The board of directors of the issuer accepted Dr. Salkind's offer to convert $510,000 of convertible notes at a reduced conversion price of $1.25 per share into 408,000 common shares and warrants to purchase 204,000 shares at an exercise price of $4.00 per share through September 30, 2029."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Left blank intentionally."}],"balance_after":0,"derivative":{"exercise_price":1.25,"exercise_date":"2019-09-13","expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":510000},"source":{"system":"sec-edgar","filing":"0001683168-22-004784","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316822004784/ownership.xml","form_type":"4"}},{"id":2215455,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T01:34:42.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":408000,"price":1.25,"value":510000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 2,992,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust."}],"balance_after":2992354,"source":{"system":"sec-edgar","filing":"0001683168-22-004784","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316822004784/ownership.xml","form_type":"4"}},{"id":2310756,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T18:42:15.000Z","date":"2022-03-30","kind":"purchase","acquired":true,"shares":125000,"price":4,"value":500000.0,"ownership":{"direct":false,"nature":"Trustee"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"125,000 shares were purchased at $4.00 per share in a private transaction through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee and considered indirect ownership of Gene Salkind"}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001477932-22-001943","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000147793222001943/form4.xml","form_type":"4"}},{"id":2313395,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2022-03-31T23:51:05.000Z","date":"2022-03-30","kind":"exercise","acquired":true,"shares":684166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 2,484,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust."},{"field":"security","element":"securityTitle","label":"F2","text":"After the close of business on March 29, 2022 and prior to the close of the market on March 30, 2022, the board of directors of the issuer accepted Dr. Salkind's offer to convert $2,052,500 of convertible notes at a reduced conversion price of $1.50 per share into 1,368,333 common shares and warrants to purchase 684,166 shares at an exercise price of $4.00 per share through September 30, 2029. A portion (i.e. $1,542,500) of the note conversion came directly from Dr. Salkind and his wife and a portion (i.e.$510,000) of the note conversion came directly from the trust that Dr. Salkind is the trustee."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"1,237,500 derivative securities include the following: (i) 127,500 shares underlying $510,000 of debt, convertible at $4.00 per share (excluding 50% warrant coverage - i.e. 63,750 warrants, exercisable at $4.00 per share through September 30, 2029, if and when issued); (ii) 390,625 common stock purchase warrants exercisable at $4.00 per share through September 2023; (iii) 10-year options to purchase 35,000 shares granted on December 8, 2021; and (iv) warrants to purchase 686,166 shares exercisable through September 30, 2029 which were issuable on March 30, 2022 as a result of the note conversion."}],"balance_after":1237500,"derivative":{"exercise_price":4,"exercise_date":"2022-03-30","expiration_date":"2029-09-30","underlying":"CommonStock","underlying_shares":684166},"source":{"system":"sec-edgar","filing":"0001683168-22-002246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316822002246/ownership.xml","form_type":"4"}},{"id":2313394,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Notes","published_at":"2022-03-31T23:51:05.000Z","date":"2022-03-30","kind":"exercise","acquired":false,"reported_value":2052500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 2,484,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust."},{"field":"security","element":"securityTitle","label":"F2","text":"After the close of business on March 29, 2022 and prior to the close of the market on March 30, 2022, the board of directors of the issuer accepted Dr. Salkind's offer to convert $2,052,500 of convertible notes at a reduced conversion price of $1.50 per share into 1,368,333 common shares and warrants to purchase 684,166 shares at an exercise price of $4.00 per share through September 30, 2029. A portion (i.e. $1,542,500) of the note conversion came directly from Dr. Salkind and his wife and a portion (i.e.$510,000) of the note conversion came directly from the trust that Dr. Salkind is the trustee."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining unpaid convertible notes in the principal amount of $510,000 are convertible into 127,500 shares at $4.00 per share, excluding 63,750 warrants issuable upon conversion thereof as described in note 5."}],"balance_after":127500,"derivative":{"exercise_price":1.5,"exercise_date":"2019-09-13","expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":513125},"source":{"system":"sec-edgar","filing":"0001683168-22-002246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316822002246/ownership.xml","form_type":"4"}},{"id":2313393,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-03-31T23:51:05.000Z","date":"2022-03-30","kind":"exercise","acquired":true,"shares":1368333,"price":1.5,"value":2052499.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 2,484,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust."}],"balance_after":2484354,"source":{"system":"sec-edgar","filing":"0001683168-22-002246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316822002246/ownership.xml","form_type":"4"}},{"id":2477676,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Options","published_at":"2021-12-10T21:00:09.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"1,422,500 derivative securities include the following: (i) 675,000 shares underlying $2.7 million of debt, convertible at $4.00 per share with 50% warrant coverage (i.e. 337,500 warrants, exercisable at $4.00 per share through September 30, 2029, if and when issued); (ii) 375,000 common stock purchase warrants exercisable at $48 per share through September 20, 2023; and (iii) options to purchase 35,000 shares granted on December 8, 2021, which options necessitated this filing."}],"balance_after":1422500,"derivative":{"exercise_price":4.565,"exercise_date":"2022-02-07","expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001683168-21-006258","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316821006258/ownership.xml","form_type":"4"}},{"id":2552810,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrants","published_at":"2021-10-04T23:30:31.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":375000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Includes securities or derivative securities heldboth jointly with his spouse and in trust."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"None."}],"balance_after":1387500,"derivative":{"exercise_price":48,"exercise_date":"2021-09-30","expiration_date":"2023-09-20","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001683168-21-004684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316821004684/ownership.xml","form_type":"4"}},{"id":2552809,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock","published_at":"2021-10-04T23:30:31.000Z","date":"2021-09-30","kind":"exercise","acquired":false,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Includes securities or derivative securities heldboth jointly with his spouse and in trust."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable - reporting person converted oneshare of Series C preferred stock into 250 common shares and 250 warrants,exercisable at $48 per share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 1,500 shares of Series C preferredstock converted into 375,000 shares of common stock and a like number ofwarrants, exercisable at $48 per share through September 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"None."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Includes 375,000 common shares and 375,000warrants, exercisable at $48 per share through September 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 675,000 shares underlying $2.7million of debt convertible at $4 per share, with 50% warrant coverage (i.e. 337,500 warrants). The warrants are exercisable at $4per share through September 30, 2029, if and when, issued.The foregoing numbers exclude interest payable on the debt, which can also beconverted on the same basis."}],"balance_after":1012500,"derivative":{"exercise_date":"2018-12-04","expiration_date":"2021-09-30","underlying":"Common stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001683168-21-004684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316821004684/ownership.xml","form_type":"4"}},{"id":2552808,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T23:30:31.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":375000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Includes securities or derivative securities heldboth jointly with his spouse and in trust."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable - reporting person converted oneshare of Series C preferred stock into 250 common shares and 250 warrants,exercisable at $48 per share."}],"balance_after":1116021,"source":{"system":"sec-edgar","filing":"0001683168-21-004684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316821004684/ownership.xml","form_type":"4"}},{"id":2586238,"issuer":{"id":6954,"kind":"organization","name":"UPEXI, INC."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option Grant","published_at":"2021-08-30T23:18:30.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the \"Grant Date\"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date."},{"field":"date","element":"transactionDate","label":"F1","text":"50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the \"Grant Date\"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the \"Grant Date\"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the \"Grant Date\"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the \"Grant Date\"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001279925-21-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000127992521000006/primary_doc.xml","form_type":"4"}},{"id":2764963,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Notes","published_at":"2021-04-01T21:21:21.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes securities held directly and in family Trusts."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":1684375,"derivative":{"exercise_price":4,"exercise_date":"2021-04-01","expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001683168-21-001191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316821001191/ownership.xml","form_type":"4"}},{"id":3035783,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-09T18:22:37.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":15000000,"price":0.01,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"Includes securities held directly and in family Trusts."}],"balance_after":296318355,"source":{"system":"sec-edgar","filing":"0001683168-20-003070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316820003070/ownership.xml","form_type":"4"}},{"id":3070184,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-04T18:39:25.000Z","date":"2020-07-21","kind":"grant","acquired":true,"shares":15000000,"price":0.01,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"Includes securities held directly and in family Trusts."}],"balance_after":281318355,"source":{"system":"sec-edgar","filing":"0001683168-20-002489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316820002489/ownership.xml","form_type":"4"}},{"id":3294551,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T21:20:02.000Z","date":"2020-01-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's Amended and Restated 2010 Stock Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, all of the restricted stock units shall vest in a single installment on the date of the 2020 annual meeting of the stockholders of the issuer."}],"balance_after":179154,"source":{"system":"sec-edgar","filing":"0001209191-20-006005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000120919120006005/doc4.xml","form_type":"4"}},{"id":3306711,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Notes","published_at":"2020-01-21T18:18:47.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":2300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Excludes 14,375,000 warrants issuable upon Note Conversion."}],"balance_after":341502500,"derivative":{"exercise_price":0.08,"exercise_date":"2019-09-13","expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":28750000},"source":{"system":"sec-edgar","filing":"0001683168-20-000197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316820000197/ownership.xml","form_type":"4/A","original_submission_date":"2019-09-19"}},{"id":3306710,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T18:18:47.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":12500000,"price":0.04,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F3","text":"Includes securities held directly and in family Trusts."}],"balance_after":266318355,"source":{"system":"sec-edgar","filing":"0001683168-20-000197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316820000197/ownership.xml","form_type":"4/A","original_submission_date":"2019-09-19"}},{"id":3306709,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T18:18:47.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":127500000,"price":0.0185,"value":2358750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F3","text":"Includes securities held directly and in family Trusts."}],"balance_after":253818355,"source":{"system":"sec-edgar","filing":"0001683168-20-000197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316820000197/ownership.xml","form_type":"4/A","original_submission_date":"2019-09-19"}},{"id":3306708,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T18:18:47.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":35000000,"price":0.0096,"value":336000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F3","text":"Includes securities held directly and in family Trusts."}],"balance_after":126318355,"source":{"system":"sec-edgar","filing":"0001683168-20-000197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316820000197/ownership.xml","form_type":"4/A","original_submission_date":"2019-09-19"}},{"id":3321452,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-01-03T21:17:58.000Z","date":"2019-12-31","kind":"exercise","acquired":false,"shares":7593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on\nDecember 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on\nDecember 31, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7593},"source":{"system":"sec-edgar","filing":"0001209191-20-000909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000120919120000909/doc4.xml","form_type":"4"}},{"id":3321451,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T21:17:58.000Z","date":"2019-12-31","kind":"exercise","acquired":true,"shares":7593,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":173154,"source":{"system":"sec-edgar","filing":"0001209191-20-000909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592481/000120919120000909/doc4.xml","form_type":"4"}},{"id":3410077,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Notes","published_at":"2019-09-19T17:49:56.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":2300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Excludes 14,375,000 warrants issuable upon Note Conversion."}],"balance_after":341502500,"derivative":{"exercise_price":0.08,"exercise_date":"2019-09-13","expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":28750000},"source":{"system":"sec-edgar","filing":"0001683168-19-002976","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002976/ownership.xml","form_type":"4"}},{"id":3410076,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T17:49:56.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":12500000,"price":0.04,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F3","text":"Includes securities held directly and in family Trusts."}],"balance_after":266318355,"source":{"system":"sec-edgar","filing":"0001683168-19-002976","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002976/ownership.xml","form_type":"4"}},{"id":3410075,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T17:49:56.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":127500000,"price":0.0185,"value":2358750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F3","text":"Includes securities held directly and in family Trusts."}],"balance_after":253818355,"source":{"system":"sec-edgar","filing":"0001683168-19-002976","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002976/ownership.xml","form_type":"4"}},{"id":3410074,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T17:49:56.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":35000000,"price":0.0096,"value":336000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."},{"field":"security","element":"securityTitle","label":"F3","text":"Includes securities held directly and in family Trusts."}],"balance_after":126318355,"source":{"system":"sec-edgar","filing":"0001683168-19-002976","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002976/ownership.xml","form_type":"4"}},{"id":3454469,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2019-07-29T12:35:12.000Z","date":"2019-07-19","kind":"grant","acquired":true,"shares":1562500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":312812500,"derivative":{"exercise_price":0.12,"exercise_date":"2019-06-18","expiration_date":"2023-09-30","underlying":"Common Stock","underlying_shares":1562500},"source":{"system":"sec-edgar","filing":"0001683168-19-002366","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002366/ownership.xml","form_type":"4"}},{"id":3454468,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T12:35:12.000Z","date":"2019-07-19","kind":"grant","acquired":true,"shares":3125000,"price":0.08,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."}],"balance_after":91318355,"source":{"system":"sec-edgar","filing":"0001683168-19-002366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002366/ownership.xml","form_type":"4"}},{"id":3454467,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T12:32:37.000Z","date":"2019-07-14","kind":"grant","acquired":true,"shares":12500000,"price":0.04,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."}],"balance_after":88193355,"source":{"system":"sec-edgar","filing":"0001683168-19-002365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002365/ownership.xml","form_type":"4"}},{"id":3454466,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2019-07-29T12:30:32.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":1562500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":311250000,"derivative":{"exercise_price":0.12,"exercise_date":"2019-06-18","expiration_date":"2023-09-30","underlying":"Common Stock","underlying_shares":1562500},"source":{"system":"sec-edgar","filing":"0001683168-19-002364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002364/ownership.xml","form_type":"4"}},{"id":3454465,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T12:30:32.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":3125000,"price":0.08,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."}],"balance_after":75693355,"source":{"system":"sec-edgar","filing":"0001683168-19-002364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819002364/ownership.xml","form_type":"4"}},{"id":3515730,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2019-05-22T18:52:31.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":3437500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":309687500,"derivative":{"exercise_price":0.12,"exercise_date":"2019-05-03","expiration_date":"2023-09-30","underlying":"Common Stock","underlying_shares":3437500},"source":{"system":"sec-edgar","filing":"0001683168-19-001688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819001688/ownership.xml","form_type":"4"}},{"id":3515729,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T18:52:31.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":6875000,"price":0.08,"value":550000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."}],"balance_after":72658355,"source":{"system":"sec-edgar","filing":"0001683168-19-001688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819001688/ownership.xml","form_type":"4"}},{"id":3563055,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2019-04-04T21:20:46.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":6250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":306250000,"derivative":{"exercise_price":0.12,"exercise_date":"2019-04-03","expiration_date":"2023-09-30","underlying":"Common Stock","underlying_shares":6250000},"source":{"system":"sec-edgar","filing":"0001683168-19-000951","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819000951/ownership.xml","form_type":"4"}},{"id":3563054,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-04T21:20:46.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":12500000,"price":0.08,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes Preferred Stock Convertible into 150 Million Common Shares and Warrants to purchase an additional 150 million Common Shares."}],"balance_after":65783355,"source":{"system":"sec-edgar","filing":"0001683168-19-000951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819000951/ownership.xml","form_type":"4"}},{"id":3633410,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2019-02-26T15:59:51.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not Applicable."}],"balance_after":300000000,"derivative":{"exercise_price":0.02,"exercise_date":"2019-01-01","underlying":"Common Stock","underlying_shares":50000000},"source":{"system":"sec-edgar","filing":"0001683168-19-000496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819000496/ownership.xml","form_type":"4"}},{"id":3633409,"issuer":{"id":7618,"kind":"organization","name":"Mobiquity Technologies, Inc."},"owners":[{"id":29450,"kind":"person","name":"Salkind Gene","position":1,"cik":"0001592481","reported_name":"Salkind Gene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-26T15:59:51.000Z","date":"2019-01-14","kind":"other","acquired":true,"shares":50000000,"price":0.02,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes Preferred StockConvertible into 150 Milion Common Shares and Warrants to purchase an additional 150 million Common Shares."}],"balance_after":53283355,"source":{"system":"sec-edgar","filing":"0001683168-19-000496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084267/000168316819000496/ownership.xml","form_type":"4"}}]}